- Home
- BAOS vs RDHL Comparison
BAOS vs RDHL Comparison
Compare BAOS & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BAOS | RDHL |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 3.9M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | BAOS | RDHL |
|---|---|---|
| Price | $2.90 | $1.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 65.4K | ★ 75.2K |
| Earning Date | 12-26-2025 | 09-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $860,951.00 | ★ $9,550,000.00 |
| Revenue This Year | N/A | $381.91 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.20 | ★ 157.62 |
| 52 Week Low | $1.44 | $1.01 |
| 52 Week High | $13.66 | $7.43 |
Technical Indicators
Market Signals| Indicator | BAOS | RDHL |
|---|---|---|
| Relative Strength Index (RSI) | 45.52 | 49.51 |
| Support Level | $2.88 | $1.14 |
| Resistance Level | $3.80 | $1.26 |
| Average True Range (ATR) | 0.20 | 0.05 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 6.06 | 71.05 |
Price Performance
Historical ComparisonAbout BAOS Baosheng Media Group Holdings
Baosheng Media Group Holdings Ltd operates as a V-log streaming marketing service provider. The firm offers comprehensive marketing solutions. Its services are Internet effect marketing, V-log or short video streaming marketing including content production and operation, e-commerce marketing, original data platform system service, and AI technology. It provides one-stop and full-link deep customized marketing solutions for partners. Baosheng Group is also a core agency of domestic Internet companies such as Tencent, Alibaba, Bytedance, and Kuaishou, with performing channel marketing services, technologies, and applications.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.